Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia
- 221 Downloads
Proliferative verrucous leukoplakia (PVL) is a premalignant condition of the oral mucosa with > 70% chance of progression to squamous cell carcinoma (SCC), while lacking the common risks and behavior seen in non-PVL oral squamous carcinogenesis. PVL follows a multi-stage slow, relentless and usually multifocal expansion of surface epithelial thickening that over time takes on a verrucous architecture, eventually leading to verrucous carcinoma and/or dysplasia followed by “conventional” SCC, a process that takes years and is notoriously difficult to manage. As mucosal surfaces and carcinomas arising at these sites, are colonized by microorganisms, host receptors for microbial products have received attention as potential contributors to carcinogenesis. Studies show that microbial pattern recognition toll-like receptor (TLR)2 in various epithelial cells is upregulated in premalignant lesions and in malignant cells and can activate oncogenic pathways. Because of the highly progressive nature of PVL, we examined TLR2 expression in well-characterized PVL samples by immunohistochemistry. We found that, similar to epithelial dysplasia and SCC, PVL keratinocytes throughout the epithelial thickness showed diffuse TLR2 expression even in early stage lesions prior to onset of dysplasia. In contrast, oral mucosal samples in the absence of hyperorothokeratosis or dysplasia, expressed TLR2 primarily in the basal and parabasal layers. Given the high rates of PVL transformation and the previously established pro-cancer role of high TLR2 expression in malignant oral squamous cells, it is important to determine how its’ expression and functions are regulated in the oral squamous epithelium, and what is the specific TLR2 role in carcinogenesis.
KeywordsProliferative verrucous leukoplakia PVL Verrucous hyperplasia Toll-like receptor 2 TLR2 Squamous epithelium Squamous cell carcinoma Oral cancer
Cluster of differentiation 282
Extracellular signal regulated kinase
Hematoxylin and eosin
Mitogen-activated protein kinase
Phosphate buffered saline
Proliferative verrucous leukoplakia
Squamous cell carcinoma
We thank Ms. Regina Hand, histotechnologist at the Dental College of Georgia, for providing sections of archival specimens for the study. This study was supported by Augusta University Pilot Project Grant.
Compliance with Ethical Standards
Conflict of interest
Authors have no conflicts of interest to disclose.
- 1.International Agency for Research on Cancer: WHO classification of head and neck tumours, 4th ed. 2017;Lyon: IARC.Google Scholar
- 3.Neville BWDD, Allen CM, Chi AC Oral and maxillofacial pathology, 4th ed. 2016;Amsterdam: Elsevier.Google Scholar
- 15.Kurago ZB, Lam-ubol A, Stetsenko A, De La Mater C, Chen Y, Dawson DV. Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation. Head Neck Pathol. 2008;2(1):1–12. https://doi.org/10.1007/s12105-007-0038-x.CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC, et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol. 2013;133(4):988–98. https://doi.org/10.1038/jid.2012.437.CrossRefPubMedGoogle Scholar
- 23.Chavarria-Velazquez CO, Torres-Martinez AC, Montano LF, Rendon-Huerta EP. TLR2 activation induced by H. pylori LPS promotes the differential expression of claudin-4, -6, -7 and -9 via either STAT3 and ERK1/2 in AGS cells. Immunobiology. 2018;223(1):38–48. https://doi.org/10.1016/j.imbio.2017.10.016.CrossRefPubMedGoogle Scholar
- 26.Hanson PJ, Moran AP, Butler K. Paracellular permeability is increased by basal lipopolysaccharide in a primary culture of colonic epithelial cells; an effect prevented by an activator of Toll-like receptor-2. Innate Immun. 2011;17(3):269–82. https://doi.org/10.1177/1753425910367813.CrossRefPubMedGoogle Scholar